2016 consultation responses

The Royal Pharmaceutical Society responded to the following consultations in 2016.

January 2016

Engagement exercise for quality standard on older people with social care needs and multiple long term conditions |NICE

Freedom to speak up: whistleblowing policy for the NHS | Monitor, NHS Trust Development Authority and NHS England

Transposition of revised Mutual Recognition of Professional Qualifications (MRPQ) Directive 2005/36/EC | Department of Health

Impact assessment of implementing AoMRC headings in eDischarge summaries | HSCIC

 

February 2016

Confidentiality: a public consultation on our draft guidance: | GMC

BSI Standards Draft Review | British Standards Institution

Community Pharmacy in 2016/17 and beyond proposals | Department of Health

 

March 2016

AMR Delivery Plan | The Welsh Government

More than words | The Welsh Government

Draft London Workforce Strategic Framework | Healthy London Partnership

CQC’s Strategy 2016 to 2021: Shaping the future Royal Pharmaceutical Society response | CQC

Skin cancer quality standard | NICE

Coeliac disease quality standard | NICE

Substance Misuse Policy, Government and Corporate Business | Welsh Government

 

April 2016

Public consultation on the ANNEX 1 proposal to make Ibuprofen Seven Plus available in Pharmacies | MHRA

Contraceptive services | NICE

 

May 2016

Hip fracture (update): Quality Standard consultation | NICE

RPS response to consultation on draft standards for the use of exemptions by orthoptists to sell, supply and administer medicines | Health and Care Professions Council

RPS response to consultation on renaming the 'local anaesthetics' and 'prescription only medicines' annotations for chiropodists/podiatrists | Health and Care Professions Council

Multimorbidity consultation response | NICE

Amendments to the Human Medicines Regulations 2012: ‘Hub and spoke’ dispensing, prices of medicines on dispensing labels, labelling requirements and pharmacists' exemption. | Department of Health

Multimorbidity: clinical assessment and management | NICE

 

June 2016

Severe mental illness and substance misuse (dual diagnosis)- community health and social care | NICE

HIV testing: Increasing the uptake of HIV testing among people at higher risk of exposure | NICE

Changing how healthcare education is funded | Department of Health

Standards for Pharmacy Professionals | General Pharmaceutical Council

 

July 2016

Community pharmacy: promoting health and well-being | NICE

UK consultation on the User Requirement Specifications for the UK Medicines Verification System | UK ESM FMD Partners

Oral health promotion in the community

 

August 2016 (NB Assets/documents need to be downloaded and then hyperlinked)

Falls Prevention | NICE     
Community engagement: Improving health and wellbeing | NICE     
Priorities for the Health, Social Care and Sport Committee | National Assembly for Wales     
Inquiry into the sustainability of the health and social care workforce | Welsh Government

 

September 2016

Pharmacists working in Community Hubs | Health & Sport Committee, Scotttish Parliament     
National Data Guardian for Health and Care’s Review of Data Security, Consent and Opt-Outs | Department of Health     
Sexually transmitted infections: condom distribution schemes | NICE     
Regional Medicines Optimisation Committees: Proposals for Establishment | NHS England     
Select Committee on the long-term sustainability of the NHS | The House of Lords Select Committee     
Leaving the EU: Implications and Opportunities for Science and Research | House of Commons Select Committee     
Inquiry into winter preparedness 2016/17 | Health, Social Care and Sport Committee     
FIP Workforce Vision Statement and Workforce Development Goals | International Pharmaceutical Federation (FIP)

 

October 2016

Reporting and acting on child abuse and neglect | Home Office and Department for Education

Return To Top